
Bharath Biotech vaccine approved for trial on children above 12 years, Covishield above age 18
Bharat Biotech’s anti-coronavirus vaccine ‘Covaxin’, which received emergency approval for administration from India’s central drug authority on January 4, has been given the permission to


















